|Articles|October 7, 2020

How one OD uses Oxervate for corneal healing

There is treatment hope for neurotrophic keratitis, a rare disease affecting the cornea.

Scott Schachter, OD, reviews Oxervate, the first FDA-approved treatment for neurotrophic keratitis to exhibit complete corneal healing.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.


Latest CME